Mercalis nyilvános
[search 0]
Több
Download the App!
show episodes
 
Mercalis is an integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company partners closely with its clients to deliver an end-to-end spectrum of commercial capabilities that work together seamlessly and flexibly. Backed by proven industry expertise and results-driven technology, Mercalis provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help lif ...
  continue reading
 
Loading …
show series
 
Today on Mercalis in Motion, we’re pleased to share a two-part episode featuring three of our colleagues from Triangle Insights Group by Mercalis. Triangle, acquired by Mercalis in April 2022, is a premier strategy consulting firm providing guidance on critical business issues to life science industry leaders. On this episode, Matt Haynes and Meghn…
  continue reading
 
Rare Disease Day is an observance that takes place worldwide to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. Rare Disease Day typically takes place on or near the last day of February. In this episode of Mercalis in Motion, Landy and Eric welcome …
  continue reading
 
In this episode, our hosts Landy Townsend, Vice President of Marketing and Communications, and Eric Manning, Creative Director, take a look back at 2023, highlighting notable guests and key discussions from the past 12 months. No frills or fluff—just a recap of some of the people and topics that made an impact. Whether you're a regular listener or …
  continue reading
 
Copay accumulators have been a major topic of discussion in the life sciences community for the past several years, and Mercalis has been extremely busy providing continued guidance and support to our clients who have been impacted. After several recent legal developments, we decided to devote an episode of our Mercalis in Motion podcast to discuss…
  continue reading
 
In this episode of Mercalis in Motion, we welcome to the studio Mercalis CEO Scott Dulitz to discuss TrialCard’s recent rebranding initiative that resulted in the creation of Mercalis. Scott discusses the reasons that led to the rebranding, how we arrived at the name Mercalis, and what’s next for the growing integrated life sciences commercializati…
  continue reading
 
Diana Villanova, TrialCard’s VP of Patient Support Services Strategy, joins Landy and Eric on today’s episode, to discuss Alternate Funding Programs (AFPs). Designed to limit plan sponsors’ financial exposure, the increased use of AFPs has introduced new access challenges for patients, plans, and manufacturers alike.…
  continue reading
 
The Drug Provisions within the Inflation Reduction Act (IRA) of 2022 are of critical importance to pharmaceutical manufacturers, who now have a host of new considerations when thinking through their portfolio strategies and pricing and market access considerations. In this episode of TrialCard TALK, Landy and Eric welcome to the studio two experts …
  continue reading
 
In this episode of TrialCard TALK, Landy and Eric welcome to the studio Dean Erhardt, President & CEO of D2 Solutions. D2 is a healthcare solutions company that leverages consulting expertise with SaaS-based technology tools to drive revenue, enhance operational efficiency, and decrease exposure to regulatory risk for pharma and biotech manufacture…
  continue reading
 
In the final episode of TrialCard TALK for 2022, our hosts Landy Townsend, Vice President of Marketing and Communications, and Eric Manning, Associate Creative Director, reflect on the guests we have featured during the year and some of the highlights from each insightful conversation. Download now to enjoy the best of our 2022 discussions.…
  continue reading
 
In the latest episode of TrialCard TALK, we speak to Bill Dupere, VP for Product Development for Patient Services, and Stephanie Chesebro, Product Owner – eServices on our IT Development Team, about TrialCard’s eServices and ‘Orchestrator’ solution. Bill and Stephanie explain how Orchestrator allows our life science clients to access many eService …
  continue reading
 
In this episode of TrialCard TALK, we are joined by Tim Ogren, General Manager, and Peter Weissberg, Managing Director, at Policy Reporter – a TrialCard Company. Tim and Peter speak to us about the difference that the company makes to its clients – and ultimately, patients – through its innovative healthcare software solutions, which improve the wa…
  continue reading
 
In this episode of TrialCard TALK, Tom Gottschalk, Senior Director of Business Development for TrialCard, outlines how we support biotech and pharmaceutical companies’ clinical trial supply needs through our RxStudy Card™ – an innovative product that generates significant cost and time savings. Download this podcast to learn how TrialCard brings hi…
  continue reading
 
Following TrialCard’s recent acquisition of Triangle Insights Group, Landy and Eric welcome two of the strategy consulting firm’s founding partners to the studio this month. In this discussion, we speak to Gautam Aggarwal and Chris Apolito about how Triangle’s strategic capabilities, combined with TrialCard’s industry-leading suite of patient suppo…
  continue reading
 
To commemorate National Nurses Week, Landy and Eric welcomed Heather Smith, PhD, RN, NNP to the studio to discuss the role that nurses play in TrialCard’s Patient Services offerings. Dr. Smith, who serves as Senior Program Director, Hub Services at TrialCard, also discusses nurses’ evolving roles through the years, the future of nursing, and what s…
  continue reading
 
In this episode of TrialCard TALK, Landy and Eric welcome to the studio Michael Carlin, General Manager of EngageHCP by TrialCard. The number of no see or difficult to see HCPs has risen dramatically in recent years and has been greatly exacerbated by COVID-19. Despite this growing trend, life science companies still must reach and educate HCPs abo…
  continue reading
 
In this episode of TrialCard TALK, Landy and Eric welcome TrialCard’s two most senior executives to the studio: Scott Dulitz, President & Chief Strategy Officer and Joe Abdalla, President & Chief Commercial Officer. Scott and Joe discuss TrialCard’s recent successes, future plans, and their vision for the full-service life sciences commercializatio…
  continue reading
 
In the latest episode of TrialCard TALK, Molly Stallings, Vice President of Product Marketing at TrialCard, discusses the evolving digital landscape and how it impacts the delivery of patient support programs. Download the podcast to hear how TrialCard is effectively engaging patients and caretakers with its life sciences multi-channel communicatio…
  continue reading
 
The risk environment facing co-pay assistance programs has expanded significantly in recent years. Legislative and policy developments, payer tactics, and ill-intentioned actors present financial, operational, and compliance issues if not properly understood and addressed. TrialCard’s TC Synapse suite combines industry-leading subject matter expert…
  continue reading
 
In this episode of TrialCard TALK, Landy and Eric welcome Mark Boesen, J.D., Pharm.D. from TC Script, TrialCard's non-commercial dispensing pharmacy located in Scottsdale, AZ. Mark discusses how TC Script has continued TrialCard's longstanding promise to always take care of patients.TrialCard által
  continue reading
 
In this podcast, Jason Zemcik, Sr. Director of Product Management at TrialCard, breaks down the implications of this rule, outlines strategies for manufacturers to address it, and provides insight on other drug pricing policy matters that could affect how manufacturers deliver patient support programs going forward. .…
  continue reading
 
In this episode, Latrinda Riley joins Landy Townsend, Vice President of Marketing at TrialCard, to discuss her new role as the Director of Diversity, Equity, and Inclusion. Listen to learn more about Latrinda’s background, how she managed challenges brought on by the COVID-19 pandemic, and the new initiatives she has planned for the organization.…
  continue reading
 
Loading …

Gyors referencia kézikönyv